Pituitary macroadenoma in a 5-year-old: An early expression of multiple endocrine neoplasia type 1

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 12, 2000, Pages 4776-4780

  Stratakis, Constantine A ^a   Schussheim, Debra H ^b   Freedman, Samuel M ^e   Keil, Margaret F ^a   Pack, Svetlana D ^c   Agarwal, Sunita K ^b   Skarulis, Monica C ^b   Weil, Robert J ^d   Lubensky, Irina A ^c   Zhuang, Zhengping ^c   Oldfield, Edward H ^d   Marx, Stephen J ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e JOE DIMAGGIO CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CASE REPORT; CHILD; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; DNA SEQUENCE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPOPHYSIS ADENOMA; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL;

ADENOMA; ALLELES; CHILD, PRESCHOOL; DNA; DNA MUTATIONAL ANALYSIS; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PITUITARY NEOPLASMS; POINT MUTATION;

EID: 17744393832     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.12.4776     Document Type: Conference Paper

References (44)

1. Positional cloning of the gene for multiple endocrine neoplasia-type 1
2. Multiple endocrine neoplasia type 1: Clinical and genetic features of the hereditary endocrine neoplasias
3. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization
4. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulimomas
5. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states
6. Identification of G protein α subunit mutatins in human growth (GH)- and GH/prolactin-secreting pituitary tumors by single strand conformation polymorphism (SSCP) analysis
7. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
8. Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3
9. Multiple endocrine neoplasia type 1
10. Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
11. Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands
12. Clinical expressions of MEN1 at NIH
13. Multiple endocrine neoplasia type 1
14. Pediatric pituitary adenomas
15. Epidemiology of pituitary adenomas
16. Pituitary adenomas in childhood and adolescence
17. Special problems with neurosurgical treatments of hormone-secreting pituitary adenomas in children
18. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas
19. Allelic loss from chromosome 11 in parathyroid tumors
20. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas
21. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinoma and pancreatic endocrine tumors
22. Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation
23. Molecular genetic studies of sporadic pituitary tumors
24. Mutations of the MEN1 tumor suppressor gene in pituitary tumors
25. Molecular characterization of the MEN1 tumor suppressor gene in sporadic pituitary tumors
26. The gene for multiple endocrine neoplasia type 1: Recent findings
27. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism
28. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated trasncription
29. Characterization of mutations in patients with multiple endocrine neoplasia type 1
30. Alternative genetic pathways in parathyroid tumorigenesis
31. Genotype/phenotype correlation of MEN1 gene mutations in sporadic gastrinomas
32. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
33. Alternative genetic pathways in parathyroid tumorigenesis
34. Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I)
35. Multiple endocrine neoplasia type I: Assessment of laboratory tests to screen for the gene in a large kindred
36. Familial multiple endocrine adenomapeptic ulcer complex
37. Hyperparathyroidism: A prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis type 1-report of a further family and a review of the literature
38. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome
39. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized?
40. Results of treatment of pituitary disease in multiple endocrine neoplasia, type I
41. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders
42. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis
43. Statement of the American society of clinical oncology: Genetic testing for cancer susceptibility; adopted on February 20, 1996
44. Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents